RSES scope. RSES evaluates publicly available research-supplier documentation. It does not guarantee product identity, safety, sterility, future-lot consistency, regulatory compliance, or suitability for human use. Research-use-only labeling is not a safety finding.
RSES interpretationconditional qualification
Category ratings
Documentation evidence profile
Analytical evidence4.3 / 5 · 28%
Lot traceability and sampling4.5 / 5 · 18%
Laboratory and method credibility4.2 / 5 · 14%
Contamination controls2.2 / 5 · 12%
Cross-lot consistency3.2 / 5 · 8%
Corporate transparency2.8 / 5 · 7%
Catalog accuracy2.4 / 5 · 5%
Corrective-action record1.5 / 5 · 4%
Community signal2.5 / 5 · 4%
Evidence sources
Documentation reviewed
[Marketing claim]
Buttondown / PeptideDr signal
Evidence class: Marketing claim. Source-list position: 5. Affiliate disclosure recorded; retained as a third-party source signal only.
Evidence class: Third-party document review. PeptideBenchmark preserved more than 140 certificate origins; Freedom Diagnostics and BioRegen records were independently indexed and lookup-linked